Abstract
Over the last two decades, there has been resurgence in the use of DCH for a number of neurological emergencies. This includes large-territory ischemic strokes with an increased risk of swelling, herniation, and death. A number of prospective randomized controlled trials, pooled analysis, and meta-analysis have shown strong evidence that the use of DCH reduces mortality in patients who develop MMI. This result is seen irrespective of age, and DCH improves mortality even in patients >60 years of age. However, long-term outcomes, patient selection, and ethical issues still require consideration. Perhaps the most important and yet controversial question that arises when considering DCH for MMI is what constitutes a favorable outcome for the patient. As such, although we can now recommend DCH as a potential therapy for patients with MMI to improve survival, the values and preferences of patients and family must be carefully weighed while arriving at a decision. This is especially pertinent in patients older than 60 years of age, in whom there is a higher likelihood of survival with severe disability. Addressing the issue of “favorable long-term outcome” involving patients and family members should always be a goal of care and should be a goal of future studies. In cases where DCH is considered, early surgery (within 24–48 h of symptom onset) is recommended, prior to onset of any herniation syndrome in order to achieve the best neurological outcome.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mak CHK, Lu YY, Wong GK. Review and recommendations on management of refractory raised intracranial pressure in aneurysmal subarachnoid hemorrhage. Vasc Health Risk Manag. 2013;9:353–9.
Treggiari MM, Schutz N, Yanez ND, Romand JA. Role of intracranial pressure values and patterns in predicting outcome in traumatic brain injury: a systematic review. Neurocrit Care. 2007;6(2):104–12.
Diringer MN, Bleck TP, Claude Hemphill J 3rd, et al. Neurocritical care society: critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society’s Multidisciplinary Consensus Conference. Neurocrit Care. 2011;15:211–40.
Wang DZ, Nair DS, Talkad AV. Acute decompressive hemicraniectomy to control high intracranial pressure in patients with malignant MCA ischemic strokes. Curr Treat Options Cardiovasc Med. 2011;13:225–32.
Heiss WD, Malignant MCA. Infarction: pathophysiology and imaging for early diagnosis and management decisions. Cerebrovasc Dis. 2016;41:1–7.
Rangel-Castillo L, Gopinath S, Robertson CS. Management of intracranial hypertension. Neurol Clin. 2008;26(2):521–41.
Doczi T. Volume regulation of the brain tissue—a survey. Acta Neurochir. 1993;121:1–8.
Scozzafava J, Shazam Hussain M, John S. In: Balestrino M, editor. Medical and surgical management of intracranial hypertension, Advances in the treatment of ischemic stroke: InTech; 2012. https://doi.org/10.5772/32754.
Van Osta A, Moraine JJ, Mélot C, Mairbäurl H, Maggiorini M, Naeije R. Effects of high altitude exposure on cerebral hemodynamics in normal subjects. Stroke. 2005;36(3):557–60.
Carter BS, Ogilvy CS, Candia GJ, et al. One-year outcome after decompressive surgery for massive non-dominant hemispheric infarction. Neurosurgery. 1997;40:1168–76.
Hauer EM, Stark D, Staykov D, Steigleder T, Schwab S, Bardutzky J. Early continuous hypertonic saline infusion in patients with severe cerebrovascular disease. Crit Care Med. 2011;39(7):1766–72.
Koenig MA, Bryan M, Lewin JL, Mirski MA, Geocadin RG, Stevens RD. Reversal of transtentorial herniation with hypertonic saline. Neurology. 2008;70(13):1023–9.
Manno EM, Adams RE, Derdeyn CP, Powers WJ, Diringer MN. The effects of mannitol on cerebral edema after large hemispheric cerebral infarct. Neurology. 1999;52(3):583–7.
Torbey MT, Bösel J, Rhoney DH, et al. Evidence-based guidelines for the management of large hemispheric infarction. Neurocrit Care. 2015;22(1):146–64.
Qizilbash N, Lewington SL, Lopez-Arrieta JM. Corticosteroids for acute ischaemic stroke. Cochrane Database Syst Rev. 2002;2:CD000064.
Schwab S, Spranger M, Schwarz S, Hacke W. Barbiturate coma in severe hemispheric stroke: useful or obsolete? Neurology. 1997;48(6):1608–13.
Clifton GL, Miller ER, Choi SC, et al. Lack of effect of induction of hypothermia after acute brain injury. N Engl J Med. 2001;344:556–63.
Schwab S, Schwarz S, Spranger M, Keller E, Bertram M, Hacke W. Moderate hypothermia in the treatment of patients with severe middle cerebral artery infarction. Stroke. 1998;29:2461–6.
Georgiadis D, Schwarz S, Aschoff A, Schwab S. Hemicraniectomy and moderate hypothermia in patients with severe ischemic stroke. Stroke. 2002;33:1584–8.
Els T, Oehm E, Voigt S, Klisch J, Hetzel A, Kassubek J. Safety and therapeutical benefit of hemicraniectomy combined with mild hypothermia in comparison with hemicraniectomy alone in patients with malignant ischemic stroke. Cerebrovasc Dis. 2006;21:79–85.
Neugebauer H, Kollmar R, Niesen WD, et al. DEcompressive surgery Plus hypoTHermia for Space-Occupying Stroke (DEPTH-SOS): a protocol of a multicenter randomized controlled clinical trial and a literature review. Int J Stroke. 2013;8:383–7.
Robertson SC, Lennarson P, Hasan DM, et al. Clinical course and surgical management of massive cerebral infarction. Neurosurgery. 2004;55:55–61. discussion 61–2.
Walz B, Zimmermann C, Böttger S, et al. Prognosis of patients after hemicraniectomy in malignant middle cerebral artery infarction. J Neurol. 2002;249:1183–90.
Schwab S, Steiner T, Aschoff A, et al. Early hemicraniectomy in patients with complete middle cerebral artery infarction. Stroke. 1998;29:1888–93.
Juttler E, Schwab S, Schmiedek P, et al. Decompressive surgery for the treatment of malignant infarction of the middle cerebral artery (DESTINY): a randomized, controlled trial. Stroke. 2007;38:2518–25.
Vahedi K, Vicaut E, Mateo J, et al. Sequential-design, multicenter, randomized, controlled trial of early decompressive craniectomy in malignant middle cerebral artery infarction (DECIMAL Trial). Stroke. 2007;38:2506–17.
Hofmeijer J, Kappelle LJ, Algra A, et al. Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol. 2009;8(4):326–33.
Vahedi K, Hofmeijer J, Juettler E, et al. Early decompressive surgery in malignant middle cerebral artery infarction: a pooled analysis of three randomized controlled trials. Lancet Neurol. 2007;6:215–22.
von Kummer R, Meyding-Lamade U, Forsting M, et al. Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. Am J Neuroradiol. 1994;15:9–15. discussion 16–8.
Juttler E, Unterberg A, Woitzik J, Bosel J, Amiri H, Sakowitz OW, et al. Hemicraniectomy in older patients with extensive middle-cerebral-artery stroke. N Engl J Med. 2014;370(12):1091–100.
Yang MH, Lin HY, Fu J, Roodrajeetsing G, Shi SL, Xiao SW. Decompressive hemicraniectomy in patients with malignant middle cerebral artery infarction: a systematic review and meta-analysis. Surgeon. 2015;13:230–40.
Back L, Nagaraja V, Kapur A, Eslick GD. Role of decompressive hemicraniectomy in extensive middle cerebral artery strokes: a metaanalysis of randomised trials. Intern Med J. 2015;45:711–7.
Puetz V, Campos CR, Eliasziw M, Hill MD, Demchuk AM, Calgary Stroke Program. Assessing the benefits of hemicraniectomy: what is a favourable outcome? Lancet Neurol. 2007;6:580. author reply 580–581
Honeybul S, Ho KM, Gillett G. Outcome following decompressive hemicraniectomy for malignant cerebral infarction. Stroke. 2015;46(9):2695–8.
Dworkin R. Ch 8. Life past reason. In: Life’s dominion: an argument about abortion, euthanasia, and individual freedom. New York: Alfred A. Knopf; 1993. p. 218–37.
Honeybul S, Ho KM, Blacker DW. ORACLE stroke study: opinion regarding acceptable outcome following decompressive hemicraniectomy for ischemic stroke. Neurosurgery. 2016;79(2):231–6.
Pfefferkorn T, Eppinger U, Linn J, et al. Long-term outcome after suboccipital decompressive craniectomy for malignant cerebellar infarction. Stroke. 2009;40(9):3045–50.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
John, S., Scozzafava, J., Hussain, M.S. (2019). Role of Decompressive Hemicraniectomy for Intracranial Hypertension Following Stroke. In: Spiotta, A., Turner, R., Chaudry, M., Turk, A. (eds) Management of Cerebrovascular Disorders. Springer, Cham. https://doi.org/10.1007/978-3-319-99016-3_36
Download citation
DOI: https://doi.org/10.1007/978-3-319-99016-3_36
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-99015-6
Online ISBN: 978-3-319-99016-3
eBook Packages: MedicineMedicine (R0)